David Hunter1, Michael Nevitt2, John Lynch2, Virginia Byers Kraus3, Jeffrey N Katz4, Jamie E Collins4, Mike Bowes5, Ali Guermazi6, Frank W Roemer7, Elena Losina4. 1. Rheumatology Department, Royal North Shore Hospital and Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, New South Wales, Australia. 2. Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA. 3. Duke Molecular Physiology Institute and Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina, USA. 4. Brigham and Women's Hospital, Boston, Massachusetts, USA. 5. Imorphics, Manchester, UK. 6. Department of Radiology, Boston University School of Medicine, Quantitative Imaging Center, Boston, Massachusetts, USA. 7. Department of Radiology, Boston University School of Medicine, Quantitative Imaging Center, Boston, Massachusetts, USA Department of Radiology, University of Erlangen-Nuremberg, Erlangen, Germany.
Abstract
OBJECTIVE: To perform a longitudinal validation study of imaging bone biomarkers of knee osteoarthritis (OA) progression. METHODS: We undertook a nested case-control study within the Osteoarthritis Initiative in knees (one knee per subject) with a Kellgren and Lawrence grade of 1-3. Cases were defined as knees having the combination of medial tibiofemoral radiographic progression and pain progression at the 24-month, 36-month or 48-month follow-up compared with baseline. Controls (n=406) were eligible knees that did not meet both endpoint criteria and included 200 with neither radiographic nor pain progression, 103 with radiographic progression only and 103 with pain progression only. Bone surfaces in medial and lateral femur, tibia and patella compartments were segmented from MR images using active appearance models. Independent variables of primary interest included change from baseline to 24 months in (1) total area of bone and (2) position on three-dimensional (3D) bone shape vectors that discriminate OA versus non-OA shapes. We assessed the association of bone markers changes over 24 months with progression using logistic regression. RESULTS: 24-month changes in bone area and shape in all compartments were greater in cases than controls, with ORs of being a case per 1 SD increase in bone area ranging from 1.28 to 1.71 across compartments, and per 1 SD greater change in 3D shape vectors ranging from 1.22 to 1.64. Bone markers were associated most strongly with radiographic progression and only weakly with pain progression. CONCLUSIONS: In knees with mild-to-moderate radiographic OA, changes in bone area and shape over 24 months are associated with the combination of radiographic and pain progression over 48 months. This finding of association with longer term clinical outcome underscores their potential for being an efficacy of intervention biomarker in clinical trials. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
OBJECTIVE: To perform a longitudinal validation study of imaging bone biomarkers of knee osteoarthritis (OA) progression. METHODS: We undertook a nested case-control study within the Osteoarthritis Initiative in knees (one knee per subject) with a Kellgren and Lawrence grade of 1-3. Cases were defined as knees having the combination of medial tibiofemoral radiographic progression and pain progression at the 24-month, 36-month or 48-month follow-up compared with baseline. Controls (n=406) were eligible knees that did not meet both endpoint criteria and included 200 with neither radiographic nor pain progression, 103 with radiographic progression only and 103 with pain progression only. Bone surfaces in medial and lateral femur, tibia and patella compartments were segmented from MR images using active appearance models. Independent variables of primary interest included change from baseline to 24 months in (1) total area of bone and (2) position on three-dimensional (3D) bone shape vectors that discriminate OA versus non-OA shapes. We assessed the association of bone markers changes over 24 months with progression using logistic regression. RESULTS: 24-month changes in bone area and shape in all compartments were greater in cases than controls, with ORs of being a case per 1 SD increase in bone area ranging from 1.28 to 1.71 across compartments, and per 1 SD greater change in 3D shape vectors ranging from 1.22 to 1.64. Bone markers were associated most strongly with radiographic progression and only weakly with pain progression. CONCLUSIONS: In knees with mild-to-moderate radiographic OA, changes in bone area and shape over 24 months are associated with the combination of radiographic and pain progression over 48 months. This finding of association with longer term clinical outcome underscores their potential for being an efficacy of intervention biomarker in clinical trials. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Entities:
Keywords:
Knee Osteoarthritis; Magnetic Resonance Imaging; Osteoarthritis
Authors: L F Schaefer; M Sury; M Yin; S Jamieson; I Donnell; S E Smith; J A Lynch; M C Nevitt; J Duryea Journal: Osteoarthritis Cartilage Date: 2017-01-30 Impact factor: 6.576
Authors: W Wirth; D J Hunter; M C Nevitt; L Sharma; C K Kwoh; C Ladel; F Eckstein Journal: Osteoarthritis Cartilage Date: 2017-08-31 Impact factor: 6.576
Authors: Adam G Culvenor; Wolfgang Wirth; Melanie Roth; David J Hunter; Felix Eckstein Journal: Am J Phys Med Rehabil Date: 2016-12 Impact factor: 2.159
Authors: Valentina Pedoia; Favian Su; Keiko Amano; Qi Li; Charles E McCulloch; Richard B Souza; Thomas M Link; Benjamin C Ma; Xiaojuan Li Journal: J Orthop Res Date: 2016-09-19 Impact factor: 3.494
Authors: Virginia Byers Kraus; Jamie E Collins; David Hargrove; Elena Losina; Michael Nevitt; Jeffrey N Katz; Susanne X Wang; Linda J Sandell; Steven C Hoffmann; David J Hunter Journal: Ann Rheum Dis Date: 2016-06-13 Impact factor: 19.103
Authors: Daniel Richard; Zun Liu; Jiaxue Cao; Ata M Kiapour; Jessica Willen; Siddharth Yarlagadda; Evelyn Jagoda; Vijaya B Kolachalama; Jakob T Sieker; Gary H Chang; Pushpanathan Muthuirulan; Mariel Young; Anand Masson; Johannes Konrad; Shayan Hosseinzadeh; David E Maridas; Vicki Rosen; Roman Krawetz; Neil Roach; Terence D Capellini Journal: Cell Date: 2020-03-26 Impact factor: 41.582